Who Is Liable If Your Crowdfunding Pitch Is Wrong? Section 4A(c), 12(a)(2) and Rule 10b-5

If a statement in your offering materials turns out to be materially wrong, the people who can be sued are not limited to the company: under Section 4A(c) of the Securities Act, the definition of "issuer" for a Regulation Crowdfunding offering expressly includes directors, the principal executive officer, the principal financial officer, the controller or principal accounting officer, and any person who offers or sells the security in that offering. The remedy an investor can seek is rescission — the consideration paid, plus interest, less income received, on tender — or damages if they no longer hold it.

Most founders assume the filed document is the liability surface and the marketing is something else. That is backwards. These provisions are triggered by statements made "in the offer or sale" of a security and do not ask what file the statement appeared in — an ad headline, a webinar remark and a line in the Form C sit on the same footing. Below: which regime attaches to which exemption, who is personally exposed, what the defenses require, and how the marketing layer gets controlled before a raise opens.

Three liability regimes, and they are not interchangeable

An offering conducted under an exemption is exempt from registration, not from the antifraud provisions. Which provision an aggrieved investor reaches for depends on the exemption used, and the differences are large — particularly on what the plaintiff must prove versus what the issuer must disprove.

The structural point is the third column against the fourth: under Section 4A(c) and Section 12(a)(2), the plaintiff need not prove the issuer's state of mind — the issuer must affirmatively establish reasonable care. Under 17 CFR 240.10b-5, Employment of manipulative and deceptive devices, the burden sits entirely with the plaintiff, and the Supreme Court has read the rule to require scienter rather than negligence.

The clock starts on discovery, not on closing

Section 4A(c) actions proceed in accordance with Securities Act Section 13, which requires suit within one year after discovery of the untrue statement or omission — or after such discovery should have been made in the exercise of reasonable diligence — with an outer limit of three years after the sale for Section 12(a)(2)-track claims. An issuer that closed two years ago and has since restated a metric has not necessarily aged out.

Regulation Crowdfunding: the burden sits with the issuer

Reg-CF is the only one of the three exemptions with a purpose-built liability provision. 17 CFR 227.201, Disclosure requirements sets out what the Form C must contain — business description, use of proceeds, ownership and capital structure, financial condition, related-party transactions and risk factors. Section 4A(c) then makes a material misstatement or omission actionable without the purchaser proving the issuer knew. Two consequences get missed:

• Personal exposure is written into the statute. The subsection's own definition of "issuer" reaches directors and partners, the principal executive officer or officers, the principal financial officer, the controller or principal accounting officer, and any person who offers or sells the security in the offering. Corporate form does not absorb it.
• "Reasonable care" is an evidentiary posture, not an attitude. The defense requires proving something: a contemporaneous record of who verified each claim, against what source, on what date. A claim verified only in someone's recollection is hard to establish two years later.

The phrase "any person who offers or sells the security" also raises a question about paid promoters. Courts assessing who counts as a statutory seller under Section 12 have applied the test from Pinter v. Dahl (1988): a person who passed title, or who solicited the purchase motivated at least in part by their own financial interest. Compensation structure is an input to that analysis — the same reason success-fee arrangements tied to capital raised carry separate broker-registration questions for marketing agencies.

Regulation D: thinner disclosure rules, identical antifraud exposure

17 CFR 230.502, General conditions to be met imposes specified information delivery requirements only where an issuer sells to non-accredited purchasers in a Rule 506(b) offering. A Rule 506(c) offering sells only to verified accredited investors, so those requirements are not triggered. Issuers sometimes read that as a lighter overall standard. It is a lighter disclosure schedule on an unchanged antifraud regime.

What does shift is which provision applies. Federal courts, following Gustafson v. Alloyd Co. (1995), have generally read Section 12(a)(2) to reach public offerings made by means of a prospectus, which typically places a Rule 506 private placement outside its scope. The practical effect is that Rule 10b-5 becomes the primary private federal claim — a higher bar, since scienter and reliance are elements. Three exposures remain:

1. SEC enforcement under Section 17(a). Section 17(a) reaches fraud in the offer or sale, and courts have generally declined to imply a private right of action under it. That changes who brings the case, not whether exposure exists.
2. State antifraud authority. The National Securities Markets Improvement Act of 1996 preempted state registration and qualification for covered securities, but Section 18 of the Securities Act preserves state authority to investigate and bring enforcement actions for fraud or deceit.
3. The general-solicitation record. Rule 506(c) permits advertising, which generates a large, public, timestamped, third-party-archived body of statements. The exemption granting the most marketing freedom produces the most discoverable evidence — a trade-off covered in our breakdown of what founders cannot say online under Reg-D 506(c).

Regulation A+: the offering circular is a prospectus

17 CFR 230.253, Offering circular governs the Reg-A document, and a qualified Reg-A offering is a public offering conducted by means of that circular — which brings Section 12(a)(2) into play in a way it generally is not for a Rule 506 placement.

Section 11 of the Securities Act, by contrast, attaches to a registration statement. A Reg-A issuer does not file one: Form 1-A is an offering statement qualified by the Commission under the Section 3(b)(2) exemption. Section 11 is therefore generally not the operative provision for a Reg-A raise; Section 12(a)(2)'s reasonable-care standard is.

That produces a rough gradient: Reg-CF and Reg-A both carry burden-shifted standards, while Rule 506 generally leaves investors to the scienter bar of Rule 10b-5. None is a low-liability path, and the ranking should not drive an exemption decision on its own — counsel should weigh it alongside ceiling, cost, investor eligibility and reporting.

The marketing layer is part of the offering record

This is where most avoidable exposure is created, and it is a marketing-operations problem before it is a legal one. Section 4A(c), Section 12(a)(2) and Rule 10b-5 are triggered by statements made in connection with the offer or sale, and none contains a carve-out for advertising.

For Reg-CF specifically, 17 CFR 227.204, Advertising limits what an advertising notice may contain and directs investors to the intermediary's platform for the substance. That constrains the format of the notice; it does not create a safe harbour for the accuracy of what the notice says.

Across more than 200 campaigns supported under Reg-CF, Reg-D 506(c), Reg-A+ and tokenized securities offerings, the recurring failure pattern is not a deliberately false statement. It is drift — a number accurate in the filed document, rounded up in an ad, rounded again in a partner's repost, with no version history connecting the three. Controls that hold up:

1. One claim register. Every quantitative or comparative claim used in the campaign lives in a single document, each row citing its source in the filed materials and the date verified. Copy that cannot cite a row does not ship.
2. Archive what runs, and when. Ad creative, landing pages, webinar recordings and email sends, captured with timestamps. Reconstructing what an investor actually saw is the first thing anyone will ask for, and platform ad libraries are no substitute for your own record.
3. Route projections through counsel every time. Forward-looking statements are the highest-variance category in any raise. If a projection appears in marketing, its assumptions and qualifying language should trace to the filed document.
4. Brief anyone with a public voice. Founders, employees, affiliates and paid promoters speak into the same liability surface. A short written standard issued before launch is cheaper than a correction after.
5. Log every correction. When a claim changes, record what changed, when, and everywhere the prior version appeared.

Growth Turbine has provided marketing support across more than $490M in aggregate issuer-reported totals, spanning 23+ crowdfunding platforms and 25+ industries. The lesson from that volume is consistent: campaigns that treat the claim register as a launch prerequisite spend materially less time reconciling copy mid-raise, when attention belongs on conversion rather than retroactive fact-checking.

Frequently Asked Questions

Can I be personally sued over statements in my company's crowdfunding campaign?

Under Section 4A(c) of the Securities Act, the definition of "issuer" for a Regulation Crowdfunding offering expressly includes directors and partners, the principal executive officer or officers, the principal financial officer, the controller or principal accounting officer, and any person who offers or sells the security in that offering. Individual officers and directors can therefore be named alongside the company. Whether a particular person falls within that definition is a fact-specific question for counsel.

Does an exemption from SEC registration also exempt me from fraud liability?

No. Reg-CF, Reg-D and Reg-A+ are exemptions from the registration requirements of the Securities Act. The antifraud provisions — Section 17(a), Rule 10b-5, and exemption-specific provisions such as Section 4A(c) — apply to exempt offerings on their own terms. State antifraud authority is likewise preserved under Section 18 of the Securities Act even where NSMIA preempts state registration.

Do advertisements and social posts count as offering materials?

The federal antifraud provisions are triggered by statements made in the offer or sale of a security and do not distinguish by format. An ad, a landing page, a webinar remark and a founder's social post can each be a statement in the offer. For Reg-CF, Rule 204 separately limits what an advertising notice may contain, but that restriction does not insulate the accuracy of what it says.

What is the "reasonable care" defense under Section 4A(c)?

Section 4A(c) makes an issuer liable unless it sustains the burden of proof that it did not know, and in the exercise of reasonable care could not have known, of the untrue statement or omission. Because the burden sits with the issuer rather than the purchaser, the defense generally depends on contemporaneous evidence of verification — what was checked, against which source, and when. Counsel should advise on what documentation is appropriate for a specific offering.

How long after a raise closes can an investor bring a claim?

Section 4A(c) actions proceed in accordance with Securities Act Section 13, which requires suit within one year after discovery of the untrue statement or omission, or after such discovery should have been made through reasonable diligence. Section 13 sets an outer limit of three years after the sale for Section 12(a)(2)-track claims. Because the one-year clock runs from discovery rather than closing, a completed raise is not automatically beyond reach.

Is Rule 506(c) lower risk than Reg-CF because there is no Section 4A(c)?

Not in a way that should drive an exemption decision. Rule 506(c) sells only to verified accredited investors and is generally outside Section 12(a)(2) following Gustafson, leaving Rule 10b-5 and its scienter requirement as the main private federal claim. But general solicitation produces a far larger public record of statements, and enforcement authority is undiminished. Exemption selection is properly driven by ceiling, cost, investor eligibility and reporting, in consultation with counsel.

Building a campaign that survives its own paper trail

Marketing a Reg-CF raise means generating public statements at volume under a standard that puts the burden of proving diligence on the issuer — facts only in tension when copy is produced faster than it can be sourced. Our Reg-CF equity crowdfunding marketing services are built around filed-document-sourced copy for exactly this reason, and issuers running an accredited-only track can review the equivalent approach on our Reg-D 506(c) marketing page.

If you are scoping a raise and want the marketing and compliance workflows mapped together before the first ad runs, get in touch with our team.

Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute legal, financial, or investment advice. Always consult with qualified legal counsel and financial advisors before launching a capital raise.